Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022

Author:

von Schreeb Sebastian12ORCID,Pedersen Susanne Kriegel3,Christensen Hanne2,Jørgsensen Kristina Melbardis4,Harritshøj Lene Holm56,Hertz Frederik Boetius7,Ahlström Magnus Glindvad8,Lebech Anne-Mette53,Lunding Suzanne9,Nielsen Lars Nørregaard10,Gerstoft Jan3,Kronborg Gitte52,Engsig Frederik N2

Affiliation:

1. Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark

2. Department of Infectious Diseases, Copenhagen University Hospital – Amager and Hvidovre, Copenhagen, Denmark

3. Department of Infectious Diseases, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark

4. Department of Clinical Microbiology, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark

5. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

6. Department of Clinical Immunology, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark

7. Department of Clinical Microbiology, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark

8. Department of Clinical Microbiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark

9. Department of Internal Medicine, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark

10. Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital – North Zealand Hospital, Copenhagen, Denmark

Abstract

Background Pre-exposure prophylaxis (PrEP) effectively prevents HIV, but its association with sexually transmitted infections (STIs) has raised concerns about risk compensation, potentially impacting the expansion of PrEP programmes. Aim We examined the relationship between PrEP and the incidence of chlamydia, gonorrhoea and syphilis. Methods In this prospective cohort study, we compared STI rates before and after PrEP initiation among users in the capital region of Denmark (2019–2022), calculating incidence rate ratios adjusted for age and testing frequency (aIRR). To pinpoint when increases began, we plotted weekly STI rates, adjusting the timeline to correspond with PrEP initiation. Results The study included 1,326 PrEP users with a median age of 35 years. The STI incidence rate per 100,000 person-years rose from 35.3 before to 81.2 after PrEP start, with an aIRR of 1.35 (95% CI: 1.18–1.56). Notably, this increase preceded PrEP initiation by 10–20 weeks. Specific aIRR for chlamydia, gonorrhoea and syphilis were 1.23 (95% CI: 1.03–1.48), 1.24 (95% CI: 1.04–1.47) and 1.15 (95% CI: 0.76–1.72), respectively. In subanalyses for anatomical sites aIRR was 1.26 (95% CI: 1.01–1.56) for rectal chlamydia and 0.66 (95% CI: 0.45–0.96) for genital gonorrhoea. Conclusion We found a 35% increase in STI incidence associated with PrEP use. It started before PrEP initiation, challenging the assumption that PrEP leads to risk compensation. Instead, the data suggest that individuals seek PrEP during periods of heightened sexual risk-taking. Consequently, PrEP programmes should include sexual health consultations, STI testing, treatment and prevention strategies to prevent HIV and improve sexual health.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Reference30 articles.

1. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.;McCormack;Lancet,2016

2. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.;Anderson;Sci Transl Med,2012

3. World Health Organization (WHO). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Web supplement. Annex 2: Evidence to decision-making tables and supporting evidence WHO/HIV/2015.36. Geneva: WHO; 2015. Available from: http://apps.who.int/iris/bitstream/10665/189977/1/WHO_HIV_2015.36_eng.pdf?ua=1

4. AIDS Vaccine Advocacy Coalition (AVAC). The global PrEP tracker. New York: AVAC. [Accessed: 23 Dec 2023.. Available from: https://data.prepwatch.org

5. Confronting rising STIs in the era of PrEP and treatment as prevention.;Ramchandani;Curr HIV/AIDS Rep,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3